INTRACELLULAR ACCUMULATION OF NORFLOXACIN IN MYCOBACTERIUM-SMEGMATIS

被引:8
作者
CORTI, S [1 ]
CHEVALIER, J [1 ]
CREMIEUX, A [1 ]
机构
[1] FAC PHARM MARSEILLE,MICROBIOL LAB,F-13385 MARSEILLE 5,FRANCE
关键词
D O I
10.1128/AAC.39.11.2466
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To evaluate the intracellular accumulation of norfloxacin in mycobacteria, two methods were used with Mycobacterium smegmatis, A radiometric method (K. V. Cundy, C. E. Fasching, K. E. Willard, and L. R. Peterson, J. Antimicrob. Chemother. 28:391-497, 1991) was used without great modification, but the fluorometric method (P. G. S. Mortimer and L. J. V. Piddock, J. Antimicrob. Chemother. 28:639-653, 1991) was changed considerably, Indeed, adsorption of the quinolone to the bacterial surface was characterized by measuring the level of accumulation at 0 degrees C. Taking into account the adsorption, the pH of the washing buffer was increased from 7.0 to 9.0 to improve the desorption of norfloxacin from the cell surface, Both the fluorometric method, with the technical improvement, and the radiometric method could be used to estimate the intracellular accumulation of norfloxacin, which resulted from the difference between the whole uptake measured at 37 degrees C and the adsorption measured at 0 degrees C. A total of 35 ng of norfloxacin per mg of cells (dry weight) penetrated into the M.smegmatis cell, and the steady state was achieved in 5 min, Use of inhibitors of the proton motive force revealed that transport of norfloxacin was energy independent, Thus, the same mechanisms of quinolone accumulation that occur in eubacteria seem to occur in mycobacteria, at least in M. smegmatis.
引用
收藏
页码:2466 / 2471
页数:6
相关论文
共 44 条
[2]   ACCUMULATION OF ENOXACIN BY ESCHERICHIA-COLI AND BACILLUS-SUBTILIS [J].
BEDARD, J ;
WONG, S ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1348-1354
[3]   SELECTION OF A GYRA MUTANT OF MYCOBACTERIUM-TUBERCULOSIS RESISTANT TO FLUOROQUINOLONES DURING TREATMENT WITH OFLOXACIN [J].
CAMBAU, E ;
SOUGAKOFF, W ;
BESSON, M ;
TRUFFOTPERNOT, C ;
GROSSET, J ;
JARLIER, V .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :479-483
[4]   INVITRO ACTIVITY OF SPARFLOXACIN COMPARED WITH THOSE OF 5 OTHER QUINOLONES [J].
CANTON, E ;
PEMAN, J ;
JIMENEZ, MT ;
RAMON, MS ;
GOBERNADO, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :558-565
[5]   ROUTES OF QUINOLONE PERMEATION IN ESCHERICHIA-COLI [J].
CHAPMAN, JS ;
GEORGOPAPADAKOU, NH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) :438-442
[6]   FLUOROMETRIC ASSAY FOR FLEROXACIN UPTAKE BY BACTERIAL-CELLS [J].
CHAPMAN, JS ;
GEORGOPAPADAKOU, NH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :27-29
[7]   ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].
COHEN, SP ;
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
MCMURRY, LM ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191
[8]   INVITRO ACTIVITY OF 17 ANTIMICROBIAL COMPOUNDS AGAINST 7 SPECIES OF MYCOBACTERIA [J].
COLLINS, CH ;
UTTLEY, AHC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (06) :857-861
[9]   MYCOBACTERIA AS COFACTORS IN AIDS [J].
COLLINS, FM .
RESEARCH IN MICROBIOLOGY, 1992, 143 (04) :369-372
[10]  
CREMIEUX A, 1978, ANN INST PASTEUR MIC, VB129, P49